Neurocrine Biosciences
NBIX
#1655
Rank
NZ$22.12 B
Marketcap
NZ$220.47
Share price
1.23%
Change (1 day)
5.58%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend yield history for this company